The challenge with Brello specifically is that getting dosing adjustments or clinical guidance during a plateau may require more proactive effort on your part, since the support structure is lighter than at higher-touch providers
References Kruchi, K., Cajochen, C., Pache, M., Flammer, J., & WirzJustice, A
Check appearance before use
Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking certain type 2 diabetes and obesity medicines
3094 Gastrointestinal (GI) Injury Allegations MDL 3094 consolidates claims alleging that certain GLP1 receptor agonists (and related incretin therapies) caused or contributed to gastrointestinal injuries such as gastroparesis, ileus/intestinal obstruction, and gallbladderrelated events
In the proposed rule (90 FR 33758), we acknowledged that updating EHRs with new measures requires some initial investment from hospitals, but in the long-term it would automate timely collection of more granular quality information
